With a market valuation of ₹509.10 Cr, Zim Laboratories Ltd. is a small capitalization company active in the pharmaceutical industry. The company is involved in the development, production and delivery of specific generic pharmaceutical products in solid oral doses in addition to providing finished formulations (FF) and pre-formulation intermediates (PFI) for a number of major therapeutic categories. . The company released its second quarter results along with a 2:1 free share issue.
- VSEZ nods for production of Covid drugs – The New Indian Express
- Comprehensive Report on Benzene-Toluene-Xylene (Btx) Market Research Report to 2027 – Cumulative Impact of COVID-19
- Oncodesign launches its new DRIVE-MRT ™ service offering in partnership with Covalab, CheMatech and ABX-CRO
- China, Indonesia to Collaborate on Drug Regulatory Issues | 2021-06-29